Transaction DateRecipientSharesTypePriceValue
28th April 2020Xiaochun Xu621,637Other acquisition or disposition$1.80$1,118,946.60
13th February 2020Xiaochun Xu1,666,670Conversion of derivative$1.80$3,000,006.00
26th December 2019Xiaochun Xu683,824Open or private purchase$2,277,134.00$1,557,158,880,416.00
26th December 2019Xiaochun Xu683,824Open or private purchase$2,277,134.00$1,557,158,880,416.00
Thermogenesis
Thermogenesis logo

Cesca Therapeutics, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice. The Clinical Development segment develops autologous stem cell- based therapeutics.

Ticker: KOOL
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 811212
Employees: 53
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals